For second time in seven months, India is running short of TB drugs, putting patients at risk

The Centre, which is responsible for supplying the medicines, has asked states to arrange medicines locally.

#health #tuberculosis #TB #TBDrugs #4FDC #3FDC #DRTB #DrugResistantTB #CMSS #HealthMinistry #UnionGovt #india

https://scroll.in/article/1066080/for-second-time-in-seven-months-india-is-running-short-of-tb-drugs-putting-patients-at-risk

For second time in seven months, India is running short of TB drugs, putting patients at risk

The Centre, which is responsible for supplying the medicines, has asked states to arrange medicines locally.

Scroll.in

'Disregards Struggles': Civil Society Groups Slam Govt's Denial of TB Drugs Shortage

Ministry of health claims the required drugs of TB patients are available for six months. Civil Society groups calculations show they are not there even for three months.

https://thewire.in/health/civil-society-groups-slam-health-ministry-denial-tb-drugs-shortage

#tuberculosis #TBDrugs #DrugResistantTB #DRTB #health #healthcare #UnionGovt #medicine #WHO #india

'Disregards Struggles': Civil Society Groups Slam Govt's Denial of TB Drugs Shortage

Ministry of health claims the required drugs of TB patients are available for six months. Civil Society groups calculations show they are not there even for three months.

The Wire

Unprecedented TB Drugs Stock-Out in India: Union Health Minister Skips UN High-Level Meet

'The Wire' spoke to several individuals across India, who are affected by the acute shortage of TB drugs in the country. The WHO has described this situation as 'worrying', while the state TB officials call it 'frustrating'.

https://thewire.in/health/will-the-un-high-level-meeting-address-indias-problem-of-tb-drugs-stock-out-situation

#tuberculosis #TB #TBDrugs #UN #WHO #MansukhMandaviya #DRTB #StopTBPartnership #GlobalTBProgramme #healthcare #health #medicine #india

Unprecedented TB Drugs Stock-Out in India: Union Health Minister Skips UN High-Level Meet

'The Wire' spoke to several individuals across India, who are affected by the acute shortage of TB drugs in the country. The WHO has described this situation as 'worrying', while the state TB officials call it 'frustrating'.

The Wire

The decision by the #India patent office opens the door for other companies to produce accessible generic versions of #TBDrugs, potentially reducing costs by 80%.

This breakthrough will help patients in low-income countries who obtain their TB drugs through the World Health Organization.

Victory over #BigPharma opens door to cheaper #tuberculosis drugs | #GenericDrugs | The Guardian
https://www.theguardian.com/global-development/2023/mar/29/victory-over-big-pharma-opens-door-to-cheaper-tuberculosis-drugs-india

Victory over big pharma opens door to cheaper tuberculosis drugs

India’s patent office turns down bedaquiline extension to Johnson & Johnson, clearing the way for generic versions

The Guardian